Abstract OT2-07-08: Substantially improving the cure rate of high-risk BRCA1-like breast cancer patients with personalized therapy (SUBITO) - an international randomized phase III... von Vliek, S, Jager, A, Jonge-Lavrencic, M, Lotz, J-P, Gonçalves, A, Graeser, M, Nitz, U, Mandjes, IAM, Holtkamp, MJ, Schot, M, Retel, VP, Kuip, EJ, Wymenga, MN, Konings, IR, Tjan-Heijnen, VCG, Kroep, JR, Schroeder, CP, Van der Wall, E, Linn, SC

Volltext

Phase II study of a multi-course high-dose chemotherapy regimen incorporating cyclophosphamide, thiotepa, and carboplatin in stage IV breast cancer von SCHRAMA, J. G, BAARS, J. W, HOLTKAMP, M. J, SCHORNAGEL, J. H, BEIJNEN, J. H, RODENHUIS, S

Volltext

Relationship between exposure and toxicity in high-dose chemotherapy with cyclophosphamide, thiotepa and carboplatin von Huitema, A. D. R., Spaander, M., Mathôt, R. A. A., Tibben, M. M., Holtkamp, M. J., Beijnen, J. H., Rodenhuis, S.

Volltext

Toxicity of the high-dose chemotherapy CTC regimen (cyclophosphamide, thiotepa, carboplatin): the Netherlands Cancer Institute experience von SCHRAMA, J. G, HOLTKAMP, M. J, BAARS, J. W, SCHORNAGEL, J. H, RODENHUIS, S

Volltext

Bone marrow reconstitution after high-dose chemotherapy and autologous peripheral blood progenitor cell transplantation: Effect of graft size von van der Wall, E., Richel, D. J., Holtkamp, M. J., Slaper-Cortenbach, I. C. M., van der Schoot, C. E., Dalesio, O., Nooijen, W. J., Schornagel, J. H., Rodenhuis, S.

Volltext

Joint Accreditation Committee of the International Society for Cellular Therapy and the European Group for Blood and Marrow Transplantation accreditation for autologous hematopoiet... von S, Huijberts, JW, Baars, HV, Tinteren, MJ, Holtkamp, S, Rodenhuis

Volltext

High-dose carboplatin, thiotepa and cyclophosphamide (CTC) with peripheral blood stem cell support in the adjuvant therapy of high-risk breast cancer: a practical approach von van der Wall, E, Nooijen, W J, Baars, J W, Holtkamp, M J, Schorangel, J H, Richel, D J, Rutgers, E J, Slaper-Cortenbach, I C, van der Schoot, C E, Rodenhuis, S

Volltext

Efficacy of up-front 5-fluorouracil - epidoxorubicin - cyclophosphamide (FEC) chemotherapy with an increased dose of epidoxorubicin in high-risk breast cancer patients von VAN DER WALL, E, RUTGERS, E. J. T, HOLTKAMP, M. J, BAARS, J. W, SCHORNAGEL, J. H, PETERSE, J. L, BEIJNEN, J. H, RODENHUIS, S

Volltext

Adjustment of the interface detector (location 71) to the absolute number of mononuclear cells in the peripheral blood: No improvement of the collection efficiency of the Fenwal CS... von Baars, J. W., Nooyen, W. J., van Beers, C., Holtkamp, M. J., te Velde, A., Dalesio, O., Slaper-Cortenbach, I. C. M., van der Schoot, C. E., Casteleyn, K.

Volltext

Newborn screening for sickle cell disease in Europe: recommendations from a Pan‐European Consensus Conference von Lobitz, S, Telfer, P, Cela, E, Allaf, B, Angastiniotis, M, Backman Johansson, C, Badens, C, Bento, C, Bouva, MJ, Canatan, D, Charlton, M, Coppinger, C, Daniel, Y, De Montalembert, M, Ducoroy, P, Dulin, E, Fingerhut, R, Frömmel, C, García-Morin, M, Gulbis, B, Holtkamp, U, Inusa, B, James, J, Kleanthous, M, Klein, J, Kunz, JB, Langabeer, L, Lapouméroulie, C, Marcao, A, Marín Soria, JL, McMahon, C, Ohene-Frempong, K, Périni, J-M, Piel, FB, Russo, G, Sainati, L, Schmugge, M, Streetly, A, Tshilolo, L, Turner, C, Venturelli, D, Vilarinho, L, Yahyaoui, R, Elion, J, Colombatti, R, With the endorsement of EuroBloodNet, the European Reference Network in Rare Haematological Diseases

Volltext